You’re invited…

The American Head and Neck Society in conjunction with the American Academy of Otolaryngology – Head & Neck Surgery are pleased to present the 2019 Head & Neck Surgery Symposium for Residents and Fellows.

Join us for this day-long symposium in New Orleans on Saturday, September 14, 2019. The symposium brings together leading head & neck surgeons, presenting informative lectures on head and neck surgical procedures and treatments. Previous lecture topics have included:

Oral Cancer
Head & Neck Reconstructive Surgery
Pharyngeal Cancer and HPV
Skin Cancer/Melanoma
Neck Dissection/Staging
Parathyroid Surgery
Thyroid Surgery
Salivary Gland
Neoplasm
Sinonasal/Skull Base
Trans Oral Laser Surgery for Head & Neck Cancer
Trans Oral Robotic Surgery
Laryngeal Cancer

The final agenda and faculty lecturers will be announced shortly. Attendees will also learn about fellowship opportunities available from AHNS-accredited programs as well as Society membership information.

The event is free to residents and fellows. A complimentary boxed lunch and a closing reception are included.

RSVP for this event by clicking HERE

The AHNS Journal Club regularly reviews the leading head and neck cancer-related journals, sharing with AHNS members some of the most relevant and important manuscripts, and providing summaries and critiques of the work.

This Issue of the AHNS Journal Club has been compiled and reviewed by  members of the AHNS Clinical Research Service: Eben Rosenthal, MD; Mark Prince, MD; Christopher Fundakowski, MD; Daniel Faden, MD

Click the links below to access the current issue of AHNS Journal Club – to review past issues – CLICK HERE

Multicenter Trial of [¹⁸F]fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Lowe VJ, Duan F, Subramaniam RM, Sicks JD, Romanoff J, Bartel T, Yu JQM, Nussenbaum B, Richmon J, Arnold CD, Cognetti D, Stack BC Jr.

 from The Journal of Clinical Oncology, July 2019

Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.

Tiedemann D, Jakobsen KK, von Buchwald C, Grønhøj C.

from Head & Neck, March 2019

Multimodality Treatment of Early-Stage Tonsil Cancer.

Roden DF, Schreiber D, Givi B.

from Otolaryngology – Head Neck Surgery, July 2017

Frameshift events predict anti–PD-1/L1 response in head and neck cancer

Glenn J. Hanna, Patrick Lizotte, Megan Cavanaugh, Frank C. Kuo, Priyanka Shivdasani, Alexander Frieden, Nicole G. Chau, Jonathan D. Schoenfeld, Jochen H. Lorch, Ravindra Uppaluri, Laura E. MacConaill, and Robert I. Haddad

from JCI Insight, February 2018

Announcing the 5^th International Salivary Gland Congress and 1^st Multidisciplinary Salivary Gland Society (MSGS) World Congress

October 25-26, 2019-5^th International Salivary Gland Congress

Preceded by the 3^rd Jefferson Sialendoscopy course October 24, 2019

Background and Historical Development of the Congress: How it all came about.

The 5^th International Salivary Gland Congress, in Philadelphia, has been in the making as early as the 3^rd International Salivary Gland Congress in Geneva, Switzerland in 2012. It will cover inflammatory diseases and neoplasms. The meeting has been endorsed by the AHNS, the AAO-HNS and the European Salivary Gland Society (ESGS). Faculty from 6 continents and over 20 countries will be speaking and/or part of the Senior Faculty Advisory Council. Abstracts are encouraged.

With  less than 3 months away, please consider joining the Multidisciplinary Salivary Gland Society (MSGS) and you will receive a discounted congress registration rate.

More information can be found here: https://oto.med.upenn.edu/wp-content/uploads/sites/25/2019/03/Program-Brochure-5th-International-Salivary-Gland-Congress.pdf

The history of the International Salivary Gland Congresses is fascinating. The first International Salivary Gland Congress was held in Geneva, Switzerland in 2002.  This pioneering event organized under the banner of the ESGS was led by Dr. Pavel Dulguerov as the president of the organizing committee and was hosted by Dr. Dulguerov and Dr. Francis Marchal. It was a multidisciplinary meeting bringing together surgeons, dentists, pathologists, radiologists, immunologists and basic scientists from several continents.

In 2007, the Second International Salivary Gland Congress was held in Pittsburgh and included a post-congress sialendoscopy lab course. Dr. Barry Schaitkin was a course director along with Dr. Francis Marchal. Notable leaders from the American Head and Neck Society included Dr Eugene Myers, Dr. David Eisele, Dr. Ricardo Carrau and Dr. Henry Hoffman. Dr. David Cognetti, Dr. Rohan Walvekar, Dr. Chris Rassekh and Dr. Robert Witt also participated.

The 3^rd International Salivary Gland Congress was again held in Geneva, Switzerland in 2012 and was accompanied by the First International Sialendoscopy Conference. Dr. Boyd Gillespie, a leader in the AHNS, participated in the Sialendoscopy conference. At this time Dr. Chris Rassekh with the support of Dr Bert O’Malley and Dr. Dulguerov raised the possibility of an International Congress in Philadelphia.

A formal proposal was initiated at the Louisiana State University Sialendoscopy course in 2016 at the pre-course Faculty Strategic Planning Meeting with Cook Medical. Dr. Michael Turner supported the proposal at the First Annual Advanced Sialendoscopy course at Mount Sinai University in New York in 2017. A survey was conducted among sialendoscopy experts in the United states between these two meetings.  Several candidate cities were proposed and Philadelphia received the most supporting votes.

Dr. Ehab Hanna played a vital role in bringing the Congress to Philadelphia at the International Federation of Otolaryngology Societies (IFOS) in Paris in June, 2017. The ESGS announced the 4^th International Salivary Gland Congress in Barcelona in October, 2017 as a part of the CEORL-HNS (Congress of European ORL-HNS). Dr. Rassekh and Dr. Witt were speakers at the meeting and at the ESGS business meeting in Barcelona, it was agreed that the next International Meeting would be in Philadelphia. Dr. Rassekh included Dr. David Cognetti and Dr. Robert Witt to be congress co-chairs given their contributions to the field and ties to Philadelphia. The meeting in Barcelona was ultimately deemed the 4^th International Congress. Commitments were established from the leadership of the University of Pennsylvania, Thomas Jefferson University and Christiana Care Health System for sponsorship of the meeting.

Dr. Cognetti has organized the highly successful 1^st and 2^nd Jefferson Sialendoscopy courses. It was determined that the 3^rd course would precede the 5^th International Salivary Gland Congress. The program and faculty were developed. Dr. Dulguerov was selected as international co-chair. The ESGS leadership (Dr. Marchal, Dr. Vincent Vander Poorten and Dr. Davide Lombardi) have provided much needed advice. Numerous faculty from the ESGS (now becoming the Multidisciplinary Salivary Gland Society), the AHNS and the AAO-HNS are involved as faculty speakers, scientific program committee or International Senior Advisory Council. The 5^th International Salivary Gland Congress will be the 1^st Multidisciplinary Salivary Gland Society (MSGS) and heralds the possible development of an International Salivary Gland Society.

The AHNS Advanced Training Council recently completed the Match process for the 2020 Fellowship year. A total of 48 AHNS-accredited programs and 55 applicants participated in the match, and we are pleased to announce the match results – congratulations to the applicants who will begin their fellowships in July of 2020:

Submit your abstract for the  Multidisciplinary Head and Neck Cancers Symposium: Expanding Treatment Horizons, taking place February 27-29, 2020, at the Westin Kierland Resort and Spa in Scottsdale, Arizona.

This meeting focuses on the multidisciplinary management of all head and neck cancers, with the goal of bringing together radiation therapy, clinical oncology and surgical oncology to examine the latest clinical trial research and new treatment approaches.